Phase I trial of neoadjuvant concurrent chemoradiotherapy with S-1 and weekly irinotecan in locally advanced rectal cancer.
第一作者:
Hye Jin,Choi
第一单位:
Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea.
作者:
主题词
腺癌(Adenocarcinoma);成年人(Adult);老年人(Aged);抗肿瘤药, 植物(Antineoplastic Agents, Phytogenic);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);喜树碱(Camptothecin);综合疗法(Combined Modality Therapy);复方合剂(Drug Combinations);女(雌)性(Female);人类(Humans);男(雄)性(Male);最大耐受剂量(Maximum Tolerated Dose);中年人(Middle Aged);肿瘤辅助疗法(Neoadjuvant Therapy);氧嗪酸(Oxonic Acid);辐射增敏药(Radiation-Sensitizing Agents);放射治疗剂量(Radiotherapy Dosage);放射疗法, 高能(Radiotherapy, High-Energy);直肠肿瘤(Rectal Neoplasms);喃氟啶(Tegafur)
DOI
10.1016/j.radonc.2008.04.001
PMID
18439695
发布时间
2018-12-01
- 浏览18
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文